CETP inhibitor more than doubles HDL cholesterol levels. Print
EurekAlert: Tuesday, Nov. 15, 2011, Cleveland, OH: Researchers at Cleveland Clinic reported today that administration of a new drug– evacetrapib – can dramatically increase HDL (good) cholesterol, while significantly lowering LDL (bad) cholesterol). At the highest tested dosage, the levels of HDL more than doubled.

...